FDA’s Nonprescription Office Adds Executive Posts To Fulfill “Safety First”
This article was originally published in The Tan Sheet
Executive Summary
FDA's office with oversight of over-the-counter drugs is adding executive positions as part of the agency's "Safety First" initiative